Sponsored by: Investment Center

Something new in your business?  Click here to submit your business press release

Chamber Corner | Main Street News | Job Hunt | Classifieds | Calendar | Illinois Lottery 

Schering-Plough posts 17 percent drop in 3Q profit

Send a link to a friend

[October 22, 2009]  KENILWORTH, N.J. (AP) -- Drugmaker Schering-Plough Corp. reports lower revenue and a smaller profit in the third quarter, partly due to slightly higher spending on taxes and research.

But the company, which soon will become part of much-larger Merck & Co., says that excluding unfavorable currency exchange rates, revenue was up 2 percent at $4.5 billion.

Schering-Plough also notes it has just launched three new products in the U.S. or other countries, including the Saphris tablet for schizophrenia and bipolar disorder. That went on sale this month in the U.S.

The Kenilworth, N.J.-based company says it had net income of $477 million, down 17 percent from $576 million in last year's third quarter.

Sales of prescription drugs were flat at $3.55 billion.

[Associated Press]

Copyright 2009 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.




< Recent articles

Back to top


News | Sports | Business | Rural Review | Teaching & Learning | Home and Family | Tourism | Obituaries

Community | Perspectives | Law & Courts | Leisure Time | Spiritual Life | Health & Fitness | Teen Scene
Calendar | Letters to the Editor